New Health Diagnostics LLC

New Health Diagnostics LLC was paid $2.17M by Medicaid between Nov 2018 and Mar 2022, across 28 billing codes. Its largest line is G0483, Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed — 9.6% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in Colorado

Rank by total paid#16 of 91

Median peer was paid$53K

This provider vs. median41×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	4,313	$72K
2019	40,511	$637K
2020	45,959	$770K
2021	28,983	$628K
2022	572	$59K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	9.6%	1,210	1,014	$208K
83992		5.0%	5,859	5,152	$107K
80365		4.7%	6,256	5,485	$101K
80361		4.6%	6,187	5,427	$100K
80346		4.6%	6,160	5,403	$100K
80373		4.5%	6,047	5,310	$98K
80349		4.5%	5,984	5,250	$97K
80356		4.5%	5,975	5,247	$97K
80354		4.5%	5,968	5,247	$97K
80358		4.4%	5,963	5,238	$96K
80372		4.4%	5,946	5,231	$96K
80353		4.4%	5,908	5,185	$95K

16 more codes

80348		4.4%	5,906	$95K
80359		4.4%	5,861	$95K
80325		3.9%	5,195	$85K
80321		3.9%	5,178	$84K
80363		2.4%	3,237	$52K
80370		2.3%	3,114	$50K
80355		2.3%	3,111	$50K
80336		2.3%	3,069	$49K
80345		2.3%	3,050	$49K
80366		2.2%	3,041	$49K
80368		2.2%	3,017	$48K
80323		2.2%	2,989	$48K
80360		2.2%	2,983	$48K
G0482	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed	1.5%	216	$33K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	1.4%	2,178	$30K
80324		<1%	730	$11K

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialYILMAZTURK, HALUK (MANAGING OWNER)

Same official

Other billing entities under YILMAZTURK, HALUK

Full network →

Provider	Location	Paid
New Health Pain Treatment Centers, LLC	Lakewood, CO	$1.54M
Rocky Mountain Pain Solutions LLC	Lakewood, CO	$229K
Englewood Surgery Center, LLC	Englewood, CO	$43K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.